At what enterprise value was NOVETUDE SANTE acquired in 2025?

During the acquisition of NOVETUDE SANTE by PEUGEOT INVEST in 2025, the transaction's Enterprise Value is estimated to be in the range of 500M - 1.5b EUR.

What was the EV/EBITDA of NOVETUDE SANTE when it was acquired by PEUGEOT INVEST?

The estimated EV/EBITDA multiple for NOVETUDE SANTE is in the range of 15x - 25x.

When was NOVETUDE SANTE acquired by PEUGEOT INVEST?

NOVETUDE SANTE was acquired by PEUGEOT INVEST in 2025.

What was the revenue of NOVETUDE SANTE at the time of the deal?

The revenue of NOVETUDE SANTE at the time of the deal is estimated to be in the range of 100M - 200M EUR.

What was the EBITDA of NOVETUDE SANTE during the acquisition?

NOVETUDE SANTE's EBITDA is estimated to be in the range of 50M - 100M EUR.

How is the data for the NOVETUDE SANTE acquisition sourced and is it reliable?

Mynth data is contributed by a professional community of M&A and Private Equity experts. Each transaction, including the NOVETUDE SANTE deal, is systematically cross-verified by our team using private deal documents and official sources. You can also find the official press release for this transaction here: https://capitalfinance.lesechos.fr/deals/lbo/novetude-sante-se-valorise-pres-de-750-meur-2164412

← DATABASE

Home Database Retail & ConsumerNOVETUDE SANTE

05/2025

NOVETUDE SANTE acquired by PEUGEOT INVEST

FRANCE Education / Education Providers EV 500M - 1.5b EUR

Context

Peugeot Invest and Hayfim acquires a majority stake in Novetude Sante from Latour Capital. This secondary LBO values the education group at nearly EUR750 million. Under Charterhouse's ownership, the group significantly expanded through buy-and-build strategies. With this operation Novetude aims to accelerate its European expansion (targeting countries like Spain and Italy) and diversify its training offerings in the booming healthcare education market.

It is worth noting that the fund Charterhouse took control of Novetude Sante through an LBO in 2020.

NOVETUDE SANTE, which reported an EBITDA margin of in 2024, is valued in this transaction at an EV/EBITDA multiple of , representing a to the average currently observed in the Retail & Consumer sector (10.9x).

-> Deep-dive in Retail & Consumer market trends

Target

Novétude Santé is a French higher education and professional training group specializing in healthcare and paramedical professions. Founded in 2010, the group offers a comprehensive range of initial and continuing education programs tailored to healthcare professionals and students aspiring to join these fields. Its portfolio spans disciplines such as osteopathy, pharmacy, medicine, dental care, and other allied health specialties. Over the years, Novétude Santé has expanded its network of institutions and programs through a combination of organic growth and targeted acquisitions. The group comprises several schools, including the ESO Paris osteopathy school, as well as complementary training organizations, enabling it to support learners throughout their professional journey, from initial training to ongoing professional development.

Ent. Value

Equity Value

Multiples

EV / Revenue

EV / EBITDA

EV / EBIT

Historical Financials (EUR)

Year

Rev

EBITDA

EBIT

2024

2023

Other operations with NOVETUDE SANTE

List of similar M&A transactions (Date, Acquirer, Target, Country, Sub-sector)
Date	Acquirer	Target	Country	Sector
11/2020	CHARTERHOUSE	NOVETUDE SANTE	FRANCE	Education Providers

REFERENCES

Valuation range: EV 500M - 1.5b EUR

Revenue range: 100M - 200M EUR

EBITDA range: 50M - 100M EUR

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of NOVETUDE SANTE by PEUGEOT INVEST are reserved for mynth community members. Register for free to unlock full data.

Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.

Target: novetude sante

Acquirer: peugeot invest